Company Filing History:
Years Active: 2025
Title: Innovations by Guangli Gan in Nucleic Acid Fragment Ligation
Introduction
Guangli Gan is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid manipulation. His innovative methods have the potential to enhance the efficiency of genetic research and applications.
Latest Patents
Guangli Gan holds a patent for a method for ligating nucleic acid fragments, which includes a method for constructing a sequencing library. This patent discloses a technique that involves ligating a first nucleic acid fragment and a second nucleic acid fragment within a mixed enzyme reaction system that comprises both a DNA ligase and an RNA ligase. The first nucleic acid fragment is double-stranded DNA. Remarkably, the ligation efficiency of this method can reach 85% or more. By utilizing this ligation method to construct a sequencing library, the yield of the effective library is significantly improved.
Career Highlights
Gan is currently associated with Genemind Biosciences Company Limited, where he continues to advance his research and innovations. His work is pivotal in the development of new methodologies that can streamline genetic sequencing processes.
Collaborations
Some of his notable coworkers include Qunting Lin and Yunyang Cheng, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Guangli Gan's innovative methods in nucleic acid ligation represent a significant advancement in molecular biology. His contributions are likely to have a lasting impact on genetic research and applications.